Tag Archives: IMS Health

Drug Utilization Under Managed Medicaid

By Ben Comer | Published: April 4, 2013
Cash-strapped states are shifting patients from traditional fee-for-service Medicaid coverage to managed Medicaid plans. The IMS Institute of Healthcare Informatics took an early look at how this trend effects prescription drug utilization.
Posted in Strategy | Also tagged , , , , , , , | Leave a comment

Obamacare's Effect on Drug Spending

By Ben Comer | Published: April 4, 2012
Provisions in the Affordable Care Act (ACA) drove out-of-pocket costs down, while increasing drug spending among 19 to 25-year-olds in 2011, according to research published on Wednesday. The decline observed in overall out-of-pocket spending last year was the “first on record,” and was “largely related to the introduction of the ‘donut-hole’ subsidy for Medicare Part D [...]
Posted in FDA, R&D, Regulatory, Sales, Strategy, healthcare, patient compliance, patient education | Also tagged , , | Leave a comment

Supreme Court Strikes down Vermont Law, Upholds Rep Free Speech

By Reid Paul | Published: June 24, 2011
June 23rd was a good day for the pharmaceutical industry. The Supreme Court released two decisions that largely went pharma’s way. There was much rejoicing across the industry, and for good reason, business as usual won out. In PLIVA v. Mensing, the Court ruled that generic drug companies should comply with federal regulations instead of [...]
Posted in Legal | Also tagged , , | Leave a comment

Biosimilars Spend to Reach $2.5 Bln by 2015: IMS

By Ben Comer | Published: May 18, 2011
Global spending on biosimilars is expected to reach between $2 and $2.5 billion by 2015, up from $311 million in 2010, according to an IMS forecast. Total spend on biologics is expected to climb as high as $200 billion. On a call with reporters yesterday, Murray Aitken, executive director of the IMS Institute for Healthcare Informatics, [...]
Posted in Agency Insight, Biotech, Emerging Markets, Europe, Strategy | Also tagged , | 2 Comments

Global Market for Medicines: Regional Balance in Growth Continues to Shift, While Pipelines Begin to Show Some Promise

By Jennifer Ringler | Published: October 8, 2010
The predicted five percent to seven percent growth of the global pharma industry surpasses the four to five percent pace of increase from 2010. According to a forecast released last week by IMS Health, the value of the global pharmaceutical market is expected to grow five percent to seven percent next year, reaching $880 billion. The IMS [...]
Posted in Agency Insight, Global, Strategy | Tagged | Leave a comment